European Journal of Pharmacology 1996: Vol 304 Index

9 Pages·1996·2.7 MB·English

NEA AEt ee : :
- ra i |
v ’
et!
nae
/ ’
gt RATY +
LSEVIER European Journal of Pharmacology 304 (1996) 243-244
Author index
Acosta-Burruel, M., see Hawkinson, J.E. (304) 141 Alcohol drinking is reduced by a y,- but not by a 6-opioid receptor
Adham, N., Gerald, C., Schechter, L., Vaysse, P., Weinshank, R. and antagonist in alcohol-preferring rats (304) 7
Branchek, T. Hudson, A.L., see Lione, L.A. (304) 221
[*H]5-Hydroxytryptamine labels the agonist high affinity state of the Hyytia, P., see Honkanen, A. (304) 7
cloned rat 5-HT, receptor (304) 231
Assié, M.-B. and Koek, W.
Ikeuchi, Y., Nishizaki, T., Mori, M. and Okada, Y.
Effects of 5-HT,, receptor antagonists on hippocampal 5-hydroxy- Adenosine activates the K* channel and enhances cytosolic Ca**
tryptamine levels: (S)-WAY 100135, but not WAY 100635, has partial
release via a P;, purinoceptor in hippocampal neurons (304) 191
agonist properties (304) 15
Imura, H., see Murakami, N. (304) 129
Inoue, G., see Murakami, N. (304) 129
Battisti, C., see Federico, A. (304) 237
Ivancheva, C., see Pencheva, N. (304) 99
Bellmann, R., see Kiihler, C.M. (304) 135
Blackham, A., see Liu, Y.J. (304) 117
Jackson, D.M., see Liu, Y.J. (304) 117
Bocheva, A., see Pencheva, N. (304) 99
Bowen, W.D., see Torrence-Campbell, C. (304) 201
Kahler, C.M., Bellmann, R., Reinisch, N., Schratzberger, P., Gruber, B.
Branchek, T., see Adham, N. (304) 231
and Wiedermann, C.J.
Stimulation of human skin fibroblast migration by the neuropeptide
Choppin, A. and O’Connor, S.E.
secretoneurin (304) 135
Influence of vascular tone on vasoconstrictor responses to the 5-HT,-
Karaki, H., see Mito, K. (304) 93
like receptor agonist sumatriptan in anaesthetised rabbits (304) 87
Kato, K., see Murakami, N. (304) 129
Dimitrov, E., see Pencheva, N. (304) 99 Kaur, S. and Starr, M.
Dziedzicka-Wasylewska, M., see Maj, J. (304) 49 Motor effects of lamotrigine in naive and dopamine-depleted mice
(304) |
Kennedy, R.H., see Williamson, A.P. (304) 73
Ebert, V., see Scholze, P. (304) 155
Kimbrough, C.L., see Hawkinson, J.E. (304) 141
Endo, T., see Taniguchi, H. (304) 147
Koek, W., see Assié, M.-B. (304) 15
Erdemli, G. and Krnjevi¢, K.
Kokkola, T., see Navajas, C. (304) 173
Tolbutamide blocks Ca?*- and voltage-dependent K* currents of
Korpi, E.R., see Honkanen, A. (304) 7
hippocampal Cal neurons (304) 37
Kortezova, N., Mizhorkova, Z., Milusheva, E., Varga, G., Vizi, E.S. and
Papasova, M.
Federico, A., Battisti, C., Manneschi, L., Gaggelli, E., Tassini, M.,
Non-adrenergic non-cholinergic neuron stimulation in the cat lower
Valensin, G. and Vivi, A.
esophageal sphincter (304) 109
Amiodarone affects membrane water permeability properties of hu-
Krnjevié, K., see Erdemli, G. (304) 37
man erythrocytes and rat mitochondria (304) 237
Kuwahara, M., see Mito, K. (304) 93
Fujii, M., see Mito, K. (304) 93
Kuzuya, H., see Murakami, N. (304) 129
Gaggelli, E., see Federico, A. (304) 237
Gater, P.R., Wasserman, M.A. and Renzetti, L.M. Laitinen, J.T., see Navajas, C. (304) 173
Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced Leff, P., see Liu, Y.J. (304) 117
contractions of human bronchus and guinea-pig trachea (304) 123 Lindemann, J.P., see Williamson, A.P. (304) 73
Gerald, C., see Adham, N. (304) 231 Lione, L.A., Nutt, D.J. and Hudson, A.L.
Goodnough, D.B., see Hawkinson, J.E. (304) 141 [°H]2-(2-Benzofuranyl)-2-imidazoline: a new selective high affinity
Gruber, B., see Kahler, C.M. (304) 135 radioligand for the study of rabbit brain imidazoline 1, receptors
Gynther, J., see Navajas, C. (304) 173 (304) 221
Liu, Y.J., Jackson, D.M., Blackham, A. and Leff, P.
Han, X.Y., see Salunga, T.L. (304) 163 Partial agonist effects of BW A868C, a selective DP receptor antago-
Hashimoto, K., see Murakami, N. (304) 129 nist, on Cl~ secretion in dog tracheal epithelium (304) 117
Hawkinson, J.E., Acosta-Burruel, M., Kimbrough, C.L., Goodnough, Lowe, D., Pagel, P.S., McGough, M.F., Hettrick, D.A. and Warltier, D.C.
D.B. and Wood, P.L. Comparison of the cardiovascular effects of two novel superoxide
Steroid inhibition of [*H]SR 95531 binding to the GABA, recogni- dismutase mimetics, SC-55858 and SC-54417, in conscious dogs
tion site (304) 141 (304) 81
Hettrick, D.A., see Lowe, D. (304) 81 Luodonpiaié, M., see Pelkonen, M. (304) 55
Honka, N., see Navajas, C. (304) 173 Lyupina, Y.V., Sudakov, S.K. and Yarygin, V.N.
Honkanen, A., Vilamo, L., Wegelius, K., Sarviharju, M., Hyytia, P. and Inhibitors of Ca?*-dependent endopeptidases modulate morphine-in-
Korpi, E.R. duced effects in rats (304) 23
244 Author index
Maj, J., Dziedzicka-Wasylewska, M., Rogoz, R., Rog6z, Z. and Skuza, Sagi, N., Yamamoto, H., Yamamoto, T., Okuyama, S. and Moroji, T.
G. Possible expression of a a, site in rat pheochromocytoma (PC12)
Antidepressant drugs given repeatedly change the binding of the cells (304) 185
dopamine D, receptor agonist, [*HJN-0437, to dopamine D, recep- Salunga, T.L., Han, X.Y., Wong, S.M., Takeuchi, H., Matsunami, K.-i.,
tors in the rat brain (304) 49 Upton, C. and Mercer, A.D.
Manneschi, L., see Federico, A. (304) 237 Blocking effects of promethazine, triprolidine and their analogues on
Matsumura, N., see Mito, K. (304) 93 the excitation caused by the peptide, achatin-I (304) 163
Matsunami, K.-i., see Salunga, T.L. (304) 163 Sarviharju, M., see Honkanen, A. (304) 7
McGough, M.F., see Lowe, D. (304) 81 Schechter, L., see Adham, N. (304) 231
Mercer, A.D., see Salunga, T.L. (304) 163 Scholze, P., Ebert, V. and Sieghart, W.
Miller, A.S. and Walker, J.M. Affinity of various ligands for GABA, receptors containing a, B;y>,
Electrophysiological effects of a cannabinoid on neural activity in the Qs, Or @, By, subunits (304) 155
globus pallidus (304) 29 Schratzberger, P., see Kiihler, C.M. (304) 135
Milusheva, E., see Kortezova, N. (304) 109 Seifen, E., see Williamson, A.P. (304) 73
Mito, K., Fujii, M., Kuwahara, M., Matsumura, N., Shimizu, T., Sugano, Shimizu, T., see Mito, K. (304) 93
S. and Karaki, H. Sieghart, W., see Scholze, P. (304) 155
Antihypertensive effect of angiotensin I-converting enzyme inhibitory Skuza, G., see Maj, J. (304) 49
peptides derived from hemoglobin (304) 93 Starr, M., see Kaur, S. (304) 1
Miwa, I., see Murakami, N. (304) 129 Sudakov, S.K., see Lyupina, Y.V. (304) 23
Mizhorkova, Z., see Kortezova, N. (304) 109 Sugano, S., see Mito, K. (304) 93
Mizota, M., see Murakami, N. (304) 129 Sun, M.-K. and Reis, D.J.
Mori, M., see Ikeuchi, Y. (304) 191 Intracisternally applied angiotensin II does not excite reticulospinal
Moroji, T., see Sagi, N. (304) 185 vasomotor neurons in anesthetized rats (304) 63
Murakami, N., Ohta, M., Hashimoto, K., Kato, K., Mizota, M., Miwa, L.,
Okuda, J., Inoue, G., Kuzuya, H., Nakao, K. and Imura, H.
Takeuchi, H., see Salunga, T.L. (304) 163
Amelioration of insulin resistance in genetically obese rodents by
Taniguchi, H., Yazaki, N., Endo, T. and Nagasaki, M.
M16209, a new antidiabetic agent (304) 129
Pharmacological profile of T-0632, a novel potent and selective
CCK, receptor antagonist, in vitro (304) 147
Nagasaki, M., see Taniguchi, H. (304) 147
Tassini, M., see Federico, A. (304) 237
Nakao, K., see Murakami, N. (304) 129
Torrence-Campbell, C. and Bowen, W.D.
Navajas, C., Kokkola, T., Poso, A., Honka, N., Gynther, J. and Laitinen,
Differential solubilization of rat liver 7, and o, receptors: retention
J.T.
of a, sites in particulate fractions (304) 201
A rhodopsin-based model for melatonin recognition at its G protein-
coupled receptor (304) 173
Upton, C., see Salunga, T.L. (304) 163
Nishizaki, T., see Ikeuchi, Y. (304) 191
Nutt, D.J., see Lione, L.A. (304) 221
Valensin, G., see Federico, A. (304) 237
O’Connor, S.E., see Choppin, A. (304) 87 Varga, G., see Kortezova, N. (304) 109
Ohta, M., see Murakami, N. (304) 129 Vaysse, P., see Adham, N. (304) 231
Okada, Y., see Ikeuchi, Y. (304) 191 Vilamo, L., see Honkanen, A. (304) 7
Okuda, J., see Murakami, N. (304) 129 Vivi, A., see Federico, A. (304) 237
Okuyama, S., see Sagi, N. (304) 185 Vizi, E.S., see Kortezova, N. (304) 109
Vuolteenaho, O., see Pelkonen, M. (304) 55
Pagel, P.S., see Lowe, D. (304) 81
Papasova, M., see Kortezova, N. (304) 109
Walker, J.M., see Miller, A.S. (304) 29
Pasanen, M., see Pelkonen, M. (304) 55
Warltier, D.C., see Lowe, D. (304) 81
Pelkonen, M., Luodonpaéa, M., Vuolteenaho, O., Pasanen, M. and
Wasserman, M.A., see Gater, P.R. (304) 123
Ruskoaho, H.
Wegelius, K., see Honkanen, A. (304) 7
Cocaine increases circulating levels of atrial natriuretic peptide and
Weinshank, R., see Adham, N. (304) 231
pro atrial natriuretic peptide N-terminal fragment in conscious rats
Wiedermann, C.J., see Kahler, C.M. (304) 135
(304) 55
Williamson, A.P., Seifen, E., Lindemann, J.P. and Kennedy, R.H.
Pencheva, N., Bocheva, A., Dimitrov, E., Ivancheva, C. and Radomirov,
The positive inotropic effect of @,,-adrenoceptor stimulation is inhib-
R.
ited by 4-aminopyridine (304) 73
[Cys(O,NH,)*]enkephalin analogues and dalargin: selectivity for
Wong, S.M., see Salunga, T.L. (304) 163
5-opioid receptors (304) 99
Wood, P.L., see Hawkinson, J.E. (304) 141
Poso, A., see Navajas, C. (304) 173
Yamamoto, H., see Sagi, N. (304) 185
Radomirov, R., see Pencheva, N. (304) 99
Yamamoto, T., see Sagi, N. (304) 185
Reinisch, N., see Kahler, C.M. (304) 135
Yarygin, V.N., see Lyupina, Y.V. (304) 23
Reis, D.J., see Sun, M.-K. (304) 63
Yazaki, N., see Taniguchi, H. (304) 147
Renzetti, L.M., see Gater, P.R. (304) 123
Rogoz, R., see Maj, J. (304) 49
Rogéz, Z., see Maj, J. (304) 49 Zhang, L.
Ruskoaho, H., see Pelkonen, M. (304) 55 Muscarinic receptors in developing rat colon (304) 211
European Journal of Pharmacology 304 (1996) 245-250
Keyword index
Achatin-I (Gly-p-Phe-Ala-Asp) Angiotensin II
Excitatory neuropeptide; Promethazine; Triprolidine; Histamine H, recep- Pressor response; Medullary vasomotor neuron; Rostral ventrolateral
tor antagonist; Blocking effect; Neuron; (Snail) (Salunga, T.L. (304) 163) medulla; Vasopressin (Sun, M.-K. (304) 63)
Adrenergic component ANP (atrial natriuretic peptide)
5-Opioid receptor; Vas deferens, mouse; Cysteine sulfonamide enkephalin Cocaine; ANP, N-terminal; Mean arterial pressure; Heart rate; Right atrial
analog; Dalargin; Purinergic component; Electrical field stimulation pressure (Pelkonen, M. (304) 55)
(Pencheva, N. (304) 99)
ANP, N-terminal
a ,-Adrenoceptor subtype Cocaine; ANP (atrial natriuretic peptide); Mean arterial pressure; Heart
4-Aminopyridine; Chloroethylclonidine; Cardiac muscle, isolated; Stau- rate; Right atrial pressure (Pelkonen, M. (304) 55)
rosporine; WB4101 (Williamson, A.P. (304) 73)
Antidepressant
Affinity state
Repeated treatment; Dopamine D, receptor binding; [*H]N-0437 (Maj, J.
5-HT, receptor; Splice variant; Radioligand binding (Adham, N. (304)
(304) 49)
231)
Antihyperglycemic effect
Afterhyperpolarization
M16209; Insulin resistance; Genetically obese rodent; Hyperinsulinemic
Sulfonylurea; K* channel, Ca? *-dependent (Erdemli, G. (304) 37)
euglycemic clamp (Murakami, N. (304) 129)
Alcohol drinking
Antipain
Food intake; &-Opioid receptor; p-Opioid receptor; Reinforcement;
Morphine analgesia; Reinforcing property; Morphine dependence; With-
(Selected rat line) (Honkanen, A. (304) 7)
drawal; Leupeptin (Lyupina, Y.V. (304) 23)
Aminoalkylindole
Austin model 1
Basal ganglia; Cannabinoid; Globus pallidus; Cannabinoid receptor; Mo-
Melatonin receptor; Comparative molecular field analysis; Quantitative
tor system; Marijuana; Tetrahydrocannabinol; WIN 55,212-2; Anan-
structure-activity relationship model; Binding site; G protein-coupled
damide (Miller, A.S. (304) 29)
receptor (Navajas, C. (304) 173)
4-Aminopyridine
Basal ganglia
a,-Adrenoceptor subtype; Chloroethylclonidine; Cardiac muscle, iso-
lated; Staurosporine; WB4101 (Williamson, A.P. (304) 73) Cannabinoid; Globus pallidus; Cannabinoid receptor; Motor system; Mar-
ijuana; Tetrahydrocannabinol; WIN 55,212-2; Aminoalkylindole; Anan-
damide (Miller, A.S. (304) 29)
Amiodarone
Water exchange; NMR (nuclear magnetic resonance); Membrane
(Federico, A. (304) 237) Benzodiazepine binding site property
GABA, receptor subtype, recombinant, a4B3y2S, a4y2S, al B3y2S
(Scholze, P. (304) 155)
Amylase release
CCK, receptor; Pancreas; Gallbladder; Gallbladder contraction; T-0632
(Taniguchi, H. (304) 147) Binding assay
Pheochromocytoma (PC12) cell; Ca** uptake; Nicotine; NE-100 (N,N-
dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine HCl); o
Anandamide
Receptor (Sagi, N. (304) 185)
Basal ganglia; Cannabinoid; Globus pallidus; Cannabinoid receptor; Mo-
tor system; Marijuana; Tetrahydrocannabinol; WIN 55,212-2;
Aminoalkylindole (Miller, A.S. (304) 29) Binding site
Melatonin receptor; Comparative molecular field analysis; Quantitative
Angiotensin I-converting enzyme structure-activity relationship model; Austin model 1; G protein-coupled
Angiotensin I-converting enzyme inhibitor; Peptide; Hemoglobin; (Swine) receptor (Navajas, C. (304) 173)
(Mito, K. (304) 93)
Blocking effect
Angiotensin I-converting enzyme inhibitor Achatin-I (Gly-p-Phe-Ala-Asp); Excitatory neuropeptide; Promethazine;
Angiotensin I-converting enzyme; Peptide; Hemoglobin; (Swine) (Mito, Triprolidine; Histamine H, receptor antagonist; Neuron; (Snail) (Salunga,
K. (304) 93) T.L. (304) 163)
246 Keyword index
BQ123 Cysteine sulfonamide enkephalin analog
Endothelin receptor antagonist; Endothelin receptor subtype; Bronchus, 5-Opioid receptor; Vas deferens, mouse; Dalargin; Purinergic component;
human; Trachea, guinea-pig; Ro 47-0203; Endothelin-1; Sarafotoxin S6c Adrenergic component; Electrical field stimulation (Pencheva, N. (304)
(Gater, P.R. (304) 123) 99)
Bronchus, human Dalargin
Endothelin receptor antagonist; Endothelin receptor subtype; Trachea, 5-Opioid receptor; Vas deferens, mouse; Cysteine sulfonamide enkephalin
guinea-pig; Ro 47-0203; BQ123; Endothelin-1; Sarafotoxin S6c (Gater, analog; Purinergic component; Adrenergic component; Electrical field
P.R. (304) 123) stimulation (Pencheva, N. (304) 99)
BW A868C
Development
DP receptor; Partial agonist; Cl” secretion (Liu, YJ. (304) 117) Colon, rat; Muscarinic receptor (Zhang, L. (304) 211)
Cannabinoid
Diastolic function
Basal ganglia; Globus pallidus; Cannabinoid receptor; Motor system;
Ventricular function; Preload recruitable stroke work; Isovolumic relax-
Marijuana; Tetrahydrocannabinol; WIN 55,212-2; Aminoalkylindole;
ation; Superoxide dismutase; SC-55858; SC-54417 (Lowe, D. (304) 81)
Anandamide (Miller, A.S. (304) 29)
Dopamine
Cannabinoid receptor
Locomotion; Reserpine; Lamotrigine; (Mouse) (Kaur, S. (304) 1)
Basal ganglia; Cannabinoid; Globus pallidus; Motor system; Marijuana;
Tetrahydrocannabinol; WIN 55,212-2; Aminoalkylindole; Anandamide
Dopamine D, receptor binding
(Miller, A.S. (304) 29)
Antidepressant; Repeated treatment; [*H]N-0437 (Maj, J. (304) 49)
Cardiac muscle, isolated
4-Aminopyridine; a,-Adrenoceptor subtype; Chloroethylclonidine; Stau- DP receptor
BW A868C; Partial agonist; Cl~ secretion (Liu, Y.J. (304) 117)
rosporine; WB4101 (Williamson, A.P. (304) 73)
Ca’* release, cytosolic DTG (1,3-di-o-tolylguanidine)
P,, purinoceptor; G-protein; Protein kinase C; K* channel; Hippocampal ao Receptor; Liver, rat; Solubilization; CHAPS (3-((3-cholamidopro-
neuron (Ikeuchi, Y. (304) 191) pyl)dimethylammonio]-|-propanesulfonate); (+ )-Pentazocine (Torrence-
Campbell, C. (304) 201)
Ca** uptake
Pheochromocytoma (PC12) cell; Nicotine; NE-100 (N,N-dipropyl-2-[4- Electrical field stimulation
methoxy-3-(2-phenylethoxy)phenyl]-ethylamine HCl); Binding assay; 7 5-Opioid receptor; Vas deferens, mouse; Cysteine sulfonamide enkephalin
Receptor (Sagi, N. (304) 185) analog; Dalargin; Purinergic component; Adrenergic component
(Pencheva, N. (304) 99)
CCK, receptor
Pancreas; Gallbladder; Amylase release; Gallbladder contraction; T-0632 Lower esophageal sphincter; NANC (non-adrenergic non-cholinergic)
(Taniguchi, H. (304) 147) neurotransmission; Nicotine; Nitric oxide (NO); VIP (vasoactive intesti-
nal peptide) (Kortezova, N. (304) 109)
CHAPS § (3-[(3-cholamidopropy!)dimethylammonio]-1-propanesul-
fonate)
Endothelin-1
oa Receptor; Liver, rat; Solubilization; (+ )-Pentazocine; DTG (1,3-di-o-
Endothelin receptor antagonist; Endothelin receptor subtype; Bronchus,
tolylguanidine) (Torrence-Campbell, C. (304) 201)
human; Trachea, guinea-pig; Ro 47-0203; BQ123; Sarafotoxin S6c (Gater,
P.R. (304) 123)
Chloroethylclonidine
4-Aminopyridine; a,-Adrenoceptor subtype; Cardiac muscle, isolated;
Endothelin receptor antagonist
Staurosporine; WB4101 (Williamson, A.P. (304) 73)
Endothelin receptor subtype; Bronchus, human; Trachea, guinea-pig; Ro
47-0203; BQ123; Endothelin-1; Sarafotoxin S6c (Gater, P.R. (304) 123)
Clonidine
Imidazoline I, receptor; [°H]2-(2-Benzofurany])-2-imidazoline; Idazoxan
Endothelin receptor subtype
(Lione, L.A. (304) 221)
Endothelin receptor antagonist; Bronchus, human; Trachea, guinea-pig;
Ro 47-0203; BQ123; Endothelin-1; Sarafotoxin S6c (Gater, P.R. (304)
Cl” secretion
123)
BW A868C; DP receptor; Partial agonist (Liu, YJ. (304) 117)
Cocaine Excitatory neuropeptide
ANP (atrial natriuretic peptide); ANP, N-terminal; Mean arterial pressure; Achatin-I (Gly-b-Phe-Ala-Asp); Promethazine; Triprolidine; Histamine
H, receptor antagonist; Blocking effect; Neuron; (Snail) (Salunga, T.L.
Heart rate; Right atrial pressure (Pelkonen, M. (304) 55)
(304) 163)
Colon, rat
Development; Muscarinic receptor (Zhang, L. (304) 211) Fibroblast
Secretoneurin; Migration; Proliferation (Kahler, C.M. (304) 135)
Comparative molecular field analysis
Melatonin receptor; Quantitative structure-activity relationship model; Food intake
Austin model |; Binding site; G protein-coupled receptor (Navajas, C. Alcohol drinking; 5-Opioid receptor; 4-Opioid receptor; Reinforcement;
(304) 173) (Selected rat line) (Honkanen, A. (304) 7)
Keyword index
GABA, receptor 5-HT,, receptor antagonist
SR 95531; Neuroactive steroid; Neurosteroid; RU 5135; Pregnenolone 5-HT (5-hydroxytryptamine, serotonin) level, extracellular; Microdialysis;
sulfate; 3 a-Hydroxy-5 B-pregnan-20-one (Hawkinson, J.E. (304) 141) (S)-WAY 100135; WAY 100635 (Assié, M.-B. (304) 15)
GABA, receptor subtype, recombinant, a4B3y2S, a4y2S, 3a-Hydroxy-5 B-pregnan-20-one
al B3y2S SR 95531; Neuroactive steroid; Neurosteroid; GABA, receptor; RU
Benzodiazepine binding site property (Scholze, P. (304) 155) 5135; Pregnenolone sulfate (Hawkinson, J.E. (304) 141)
Gallbladder Hyperinsulinemic euglycemic clamp
CCK, receptor; Pancreas; Amylase release; Gallbladder contraction; M16209; Insulin resistance; Genetically obese rodent; Antihyperglycemic
T-0632 (Taniguchi, H. (304) 147) effect (Murakami, N. (304) 129)
Gallbladder contraction Idazoxan
CCK, receptor; Pancreas; Gallbladder; Amylase release; T-0632 (Tani- Imidazoline I, receptor; [°H]2-(2-Benzofurany])-2-imidazoline; Cloni-
guchi, H. (304) 147) dine (Lione, L.A. (304) 221)
Genetically obese rodent Imidazoline I, receptor
M16209; Insulin resistance; Hyperinsulinemic euglycemic clamp; Antihy- [°H]2-(2-Benzofurany])-2-imidazoline; Idazoxan; Clonidine (Lione, L.A.
perglycemic effect (Murakami, N. (304) 129) (304) 221)
Globus pallidus Insulin resistance
Basal ganglia; Cannabinoid; Cannabinoid receptor; Motor system; Mari- M16209; Genetically obese rodent; Hyperinsulinemic euglycemic clamp;
juana; Tetrahydrocannabinol; WIN 55,212-2; Aminoalkylindole; Anan- Antihyperglycemic effect (Murakami, N. (304) 129)
damide (Miller, A.S. (304) 29)
Isovolumic relaxation
G-protein Ventricular function; Preload recruitable stroke work; Diastolic function;
P,, purinoceptor; Protein kinase C; K* channel; Ca** release, cytosolic; Superoxide dismutase; SC-55858; SC-54417 (Lowe, D. (304) 81)
Hippocampal neuron (Ikeuchi, Y. (304) 191)
K* channel
G protein-coupled receptor P,, purinoceptor; G-protein; Protein kinase C; Ca** release, cytosolic;
Melatonin receptor; Comparative molecular field analysis; Quantitative Hippocampal neuron (Ikeuchi, Y. (304) 191)
structure-activity relationship model; Austin model 1; Binding site
(Navajas, C. (304) 173) K* channel, Ca**-dependent
Sulfonylurea; Afterhyperpolarization (Erdemli, G. (304) 37)
[3H]2-(2-Benzofuranyl)-2-imidazoline
Imidazoline I, receptor; Idazoxan; Clonidine (Lione, L.A. (304) 221) Lamotrigine
Locomotion; Reserpine; Dopamine; (Mouse) (Kaur, S. (304) 1)
Heart rate
Cocaine; ANP (atrial natriuretic peptide); ANP, N-terminal; Mean arterial Leupeptin
pressure; Right atrial pressure (Pelkonen, M. (304) 55) Morphine analgesia; Reinforcing property; Morphine dependence; With-
drawal; Antipain (Lyupina, Y.V. (304) 23)
Hemoglobin
Angiotensin I-converting enzyme; Angiotensin I-converting enzyme in- Liver, rat
hibitor; Peptide; (Swine) (Mito, K. (304) 93) a Receptor; Solubilization; CHAPS (3-[(3-cholamidopropy|)dimethylam-
monio]-1-propanesulfonate); (+ )-Pentazocine; DTG (1,3-di-o-
Hippocampal neuron tolylguanidine) (Torrence-Campbell, C. (304) 201)
P,, purinoceptor; G-protein; Protein kinase C; K* channel; Ca** re-
lease, cytosolic (Ikeuchi, Y. (304) 191) Locomotion
Reserpine; Lamotrigine; Dopamine; (Mouse) (Kaur, S. (304) 1)
Histamine H, receptor antagonist
Achatin-I (Gly-D-Phe-Ala-Asp); Excitatory neuropeptide; Promethazine; Lower esophageal sphincter
Triprolidine; Blocking effect; Neuron; (Snail) (Salunga, T.L. (304) 163) NANC (non-adrenergic non-cholinergic) neurotransmission; Electrical
field stimulation; Nicotine; Nitric oxide (NO); VIP (vasoactive intestinal
[> HIN-0437 peptide) (Kortezova, N. (304) 109)
Antidepressant; Repeated treatment; Dopamine D, receptor binding (Maj,
J. (304) 49) M16209
Insulin resistance; Genetically obese rodent; Hyperinsulinemic eug-
5-HT (5-hydroxytryptamine, serotonin) level, extracellular lycemic clamp; Antihyperglycemic effect (Murakami, N. (304) 129)
5-HT,, receptor antagonist; Microdialysis; (S)-WAY100135;
WAY 100635 (Assié, M.-B. (304) 15) Marijuana
Basal ganglia; Cannabinoid; Globus pallidus; Cannabinoid receptor; Mo-
5-HT,-like receptor tor system; Tetrahydrocannabinol; WIN 55,212-2; Aminoalkylindole;
Vasoconstriction; Sumatriptan; Vasoconstrictor synergy; Vascular tone; Anandamide (Miller, A.S. (304) 29)
(Rabbit, anesthetised) (Choppin, A. (304) 87)
Mean arterial pressure
5-HT, receptor Cocaine; ANP (atrial natriuretic peptide); ANP, N-terminal; Heart rate;
Splice variant; Affinity state; Radioligand binding (Adham, N. (304) 231) Right atrial pressure (Pelkonen, M. (304) 55)
248 Keyword index
Medullary vasomotor neuron Nitric oxide (NO)
Angiotensin II; Pressor response; Rostral ventrolateral medulla; Vaso- Lower esophageal sphincter; NANC (non-adrenergic non-cholinergic)
pressin (Sun, M.-K. (304) 63) neurotransmission; Electrical field stimulation; Nicotine; VIP (vasoactive
intestinal peptide) (Kortezova, N. (304) 109)
Melatonin receptor
Comparative molecular field analysis; Quantitative structure-activity rela- NMR (nuclear magnetic resonance)
tionship model; Austin model |; Binding site; G protein-coupled receptor Amiodarone; Water exchange; Membrane (Federico, A. (304) 237)
(Navajas, C. (304) 173)
6-Opioid receptor
Membrane Alcohol drinking; Food intake; p-Opioid receptor; Reinforcement;
Amiodarone; Water exchange; NMR (nuclear magnetic resonance) (Selected rat line) (Honkanen, A. (304) 7)
(Federico, A. (304) 237)
Vas deferens, mouse; Cysteine sulfonamide enkephalin analog; Dalargin;
Purinergic component; Adrenergic component; Electrical field stimulation
Microdialysis
(Pencheva, N. (304) 99)
5-HT,, receptor antagonist; 5-HT (S-hydroxytryptamine, serotonin) level,
extracellular; (S$)-WAY 100135; WAY 100635 (Assié, M.-B. (304) 15)
p-Opioid receptor
Alcohol drinking; Food intake; 6-Opioid receptor; Reinforcement;
Migration
(Selected rat line) (Honkanen, A. (304) 7)
Secretoneurin; Fibroblast; Proliferation (Kahler, C.M. (304) 135)
Pancreas
Morphine analgesia
CCK, receptor; Gallbladder; Amylase release; Gallbladder contraction;
Reinforcing property; Morphine dependence; Withdrawal; Antipain; Leu-
T-0632 (Taniguchi, H. (304) 147)
peptin (Lyupina, Y.V. (304) 23)
Partial agonist
Morphine dependence
BW A868C; DP receptor; Cl~ secretion (Liu, Y.J. (304) 117)
Morphine analgesia; Reinforcing property; Withdrawal; Antipain; Leu-
peptin (Lyupina, Y.V. (304) 23)
(+ )-Pentazocine
ao Receptor; Liver, rat; Solubilization; CHAPS (3-[(3-
Motor system
cholamidopropy|)dimethylammonio]-1-propanesulfonate); DTG (1,3-di-
Basal ganglia; Cannabinoid; Globus pallidus; Cannabinoid receptor; Mar-
o-tolylguanidine) (Torrence-Campbell, C. (304) 201)
ijuana; Tetrahydrocannabinol; WIN 55,212-2; Aminoalkylindole; Anan-
damide (Miller, A.S. (304) 29)
Peptide
Angiotensin I-converting enzyme; Angiotensin I-converting enzyme in-
Muscarinic receptor
hibitor; Hemoglobin; (Swine) (Mito, K. (304) 93)
Colon, rat; Development (Zhang, L. (304) 211)
Pheochromocytoma (PC12) cell
NANC (non-adrenergic non-cholinergic) neurotransmission
Ca** uptake; Nicotine; NE-100 (N, N-dipropyl-2-[4-methoxy-3-(2-phen-
Lower esophageal sphincter; Electrical field stimulation; Nicotine; Nitric
ylethoxy)phenyl]-ethylamine HCl); Binding assay; a Receptor (Sagi, N.
oxide (NO); VIP (vasoactive intestinal peptide) (Kortezova, N. (304) 109)
(304) 185)
NE-100 (N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)pheny!]-eth-
P,y purinoceptor
ylamine HCl)
G-protein; Protein kinase C; K* channel; Ca?* release, cytosolic; Hip-
Pheochromocytoma (PC12) cell; Ca** uptake; Nicotine; Binding assay;
pocampal neuron (Ikeuchi, Y. (304) 191)
a Receptor (Sagi, N. (304) 185)
Pregnenolone sulfate
Neuroactive steroid
SR 95531; Neuroactive steroid; Neurosteroid; GABA, receptor; RU
SR 95531; Neurosteroid; GABA, receptor; RU 5135; Pregnenolone
5135; 3a-Hydroxy-5 B-pregnan-20-one (Hawkinson, J.E. (304) 141)
sulfate; 3a-Hydroxy-5 B-pregnan-20-one (Hawkinson, J.E. (304) 141)
Preload recruitable stroke work
Neuron
Ventricular function; Diastolic function; Isovolumic relaxation; Superox-
Achatin-I (Gly-D-Phe-Ala-Asp); Excitatory neuropeptide; Promethazine; ide dismutase; SC-55858; SC-54417 (Lowe, D. (304) 81)
Triprolidine; Histamine H, receptor antagonist; Blocking effect; (Snail)
(Salunga, T.L. (304) 163)
Pressor response
Angiotensin II; Medullary vasomotor neuron; Rostral ventrolateral
Neurosteroid medulla; Vasopressin (Sun, M.-K. (304) 63)
SR 95531; Neuroactive steroid; GABA, receptor; RU 5135; Preg-
nenolone sulfate; 3 a-Hydroxy-5 B-pregnan-20-one (Hawkinson, J.E. (304) Proliferation
141) Secretoneurin; Fibroblast; Migration (Kahler, C.M. (304) 135)
Nicotine Promethazine
Lower esophageal sphincter; NANC (non-adrenergic non-cholinergic) Achatin-I (Gly-pb-Phe-Ala-Asp); Excitatory neuropeptide; Triprolidine;
neurotransmission; Electrical field stimulation; Nitric oxide (NO); VIP Histamine H, receptor antagonist; Blocking effect; Neuron; (Snail)
(vasoactive intestinal peptide) (Kortezova, N. (304) 109) (Salunga, T.L. (304) 163)
Pheochromocytoma (PC 12) cell; Ca** uptake; NE-100 (N, N-dipropyl-2- Protein kinase C
[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine HCl); Binding assay; P,, purinoceptor; G-protein; K* channel; Ca’?* release, cytosolic; Hip-
a Receptor (Sagi, N. (304) 185) pocampal neuron (Ikeuchi, Y. (304) 191)
Keyword index
Purinergic component Secretoneurin
5-Opioid receptor; Vas deferens, mouse; Cysteine sulfonamide enkephalin Fibroblast; Migration; Proliferation (Kahler, C.M. (304) 135)
analog; Dalargin; Adrenergic component; Electrical field stimulation
(Pencheva, N. (304) 99) Solubilization
ao Receptor; Liver, rat; CHAPS (3-((3-cholamidopropyl)dimethylam-
Quantitative structure-activity relationship model monio}]-1-propanesulfonate); (+ )-Pentazocine; DTG (1,3-di-o-tolylguani-
Melatonin receptor; Comparative molecular field analysis; Austin model dine) (Torrence-Campbell, C. (304) 201)
1; Binding site; G protein-coupled receptor (Navajas, C. (304) 173)
Splice variant
Radioligand binding 5-HT, receptor; Affinity state; Radioligand binding (Adham, N. (304)
5-HT, receptor; Splice variant; Affinity state (Adham, N. (304) 231) 231)
o Receptor SR 95531
Pheochromocytoma (PC12) cell; Ca** uptake; Nicotine; NE-100 (N,N- Neuroactive steroid; Neurosteroid; GABA, receptor; RU 5135; Preg-
dipropyl-2-[4-methoxy-3-(2-phenylethoxy )phenyl]-ethylamine HCl); nenolone sulfate; 3 a-Hydroxy-5 B-pregnan-20-one (Hawkinson, J.E. (304)
Binding assay (Sagi, N. (304) 185) 141)
Liver, rat; Solubilization; CHAPS (3-[(3-cholamidopropyl)dimethylam- Staurosporine
monio]-1-propanesulfonate); (+ )-Pentazocine; DTG (1,3-di-o-tolylguani- 4-Aminopyridine; a,-Adrenoceptor subtype; Chloroethylclonidine; Car-
dine) (Torrence-Campbell, C. (304) 201) diac muscle, isolated; WB4101 (Williamson, A.P. (304) 73)
Reinforcement Sulfonylurea
Alcohol drinking; Food intake; 5-Opioid receptor; u-Opioid receptor; Afterhyperpolarization; K* channel, Ca? *-dependent (Erdemli, G. (304)
(Selected rat line) (Honkanen, A. (304) 7) 37)
Reinforcing property Sumatriptan
Morphine analgesia; Morphine dependence; Withdrawal; Antipain; Leu- 5-HT,-like receptor; Vasoconstriction; Vasoconstrictor synergy; Vascular
peptin (Lyupina, Y.V. (304) 23) tone; (Rabbit, anesthetised) (Choppin, A. (304) 87)
Repeated treatment Superoxide dismutase
Antidepressant; Dopamine D, receptor binding; [*HJN-0437 (Maj, J. Ventricular function; Preload recruitable stroke work; Diastolic function;
(304) 49) Isovolumic relaxation; SC-55858; SC-54417 (Lowe, D. (304) 81)
Reserpine T-0632
Locomotion; Lamotrigine; Dopamine; (Mouse) (Kaur, S. (304) 1) CCK, receptor; Pancreas; Gallbladder; Amylase release; Gallbladder
contraction (Taniguchi, H. (304) 147)
Right atrial pressure
Cocaine; ANP (atrial natriuretic peptide); ANP, N-terminal; Mean arterial Tetrahydrocannabinol
pressure; Heart rate (Pelkonen, M. (304) 55) Basal ganglia; Cannabinoid; Globus pallidus; Cannabinoid receptor; Mo-
tor system; Marijuana; WIN 55,212-2; Aminoalkylindole; Anandamide
Ro 47-0203 (Miller, A.S. (304) 29)
Endothelin receptor antagonist; Endothelin receptor subtype; Bronchus,
human; Trachea, guinea-pig; BQI23; Endothelin-1; Sarafotoxin Sé6c Trachea, guinea-pig
(Gater, P.R. (304) 123) Endothelin receptor antagonist; Endothelin receptor subtype; Bronchus,
human; Ro 47-0203; BQ123; Endothelin-1; Sarafotoxin S6c (Gater, P.R.
Rostral ventrolateral medulla (304) 123)
Angiotensin II; Pressor response; Medullary vasomotor neuron; Vaso-
pressin (Sun, M.-K. (304) 63) Triprolidine
Achatin-I (Gly-pb-Phe-Ala-Asp); Excitatory neuropeptide; Promethazine;
RU 5135 Histamine H, receptor antagonist; Blocking effect; Neuron; (Snail)
SR 95531; Neuroactive steroid; Neurosteroid; GABA, receptor; Preg- (Salunga, T.L. (304) 163)
nenolone sulfate; 3 a-Hydroxy-5 B-pregnan-20-one (Hawkinson, J.E. (304)
141) Vascular tone
5-HT,-like receptor; Vasoconstriction; Sumatriptan; Vasoconstrictor syn-
Sarafotoxin S6c ergy; (Rabbit, anesthetised) (Choppin, A. (304) 87)
Endothelin receptor antagonist; Endothelin receptor subtype; Bronchus,
human; Trachea, guinea-pig; Ro 47-0203; BQ123; Endothelin-1 (Gater, Vas deferens, mouse
P.R. (304) 123) 5-Opioid receptor; Cysteine sulfonamide enkephalin analog; Dalargin;
Purinergic component; Adrenergic component; Electrical field stimulation
SC-54417 (Pencheva, N. (304) 99)
Ventricular function; Preload recruitable stroke work: Diastolic function;
Isovolumic relaxation; Superoxide dismutase; SC-55858 (Lowe, D. (304) Vasoconstriction
81) 5-HT, -like receptor; Sumatriptan; Vasoconstrictor synergy; Vascular tone;
(Rabbit, anesthetised) (Choppin, A. (304) 87)
SC-55858
Ventricular function; Preload recruitable stroke work: Diastolic function; Vasoconstrictor synergy
Isovolumic relaxation; Superoxide dismutase; SC-54417 (Lowe, D. (304) 5-HT,-like receptor; Vasoconstriction; Sumatriptan; Vascular tone; (Rab-
81) bit, anesthetised) (Choppin, A. (304) 87)
250 Keyword index
Vasopressin (S)-WAY100135
Angiotensin II; Pressor response; Medullary vasomotor neuron; Rostral 5-HT,, receptor antagonist; 5-HT (5-hydroxytryptamine, serotonin) level,
ventrolateral medulla (Sun, M.-K. (304) 63) extracellular; Microdialysis; WAY 100635 (Assié, M.-B. (304) 15)
Ventricular function
WB4101
Preload recruitable stroke work; Diastolic function; Isovolumic relax-
ation; Superoxide dismutase; SC-55858; SC-54417 (Lowe, D. (304) 81) 4-Aminopyridine; a,-Adrenoceptor subtype; Chloroethylclonidine; Car-
diac muscle, isolated; Staurosporine (Williamson, A.P. (304) 73)
VIP (vasoactive intestinal peptide)
Lower esophageal sphincter; NANC (non-adrenergic non-cholinergic)
WIN 55,212-2
neurotransmission; Electrical field stimulation; Nicotine; Nitric oxide
Basal ganglia; Cannabinoid; Globus pallidus; Cannabinoid receptor; Mo-
(NO) (Kortezova, N. (304) 109)
tor system; Marijuana; Tetrahydrocannabinol; Aminoalkylindole; Anan-
damide (Miller, A.S. (304) 29)
Water exchange
Amiodarone; NMR (nuclear magnetic resonance); Membrane (Federico,
A. (304) 237)
Withdrawal
Morphine analgesia; Reinforcing property; Morphine dependence; An-
WAY100635
tipain; Leupeptin (Lyupina, Y.V. (304) 23)
5-HT;, receptor antagonist; 5-HT (5-hydroxytryptamine, serotonin) level,
extracellular; Microdialysis; (S)-WAY 100135 (Assié, M.-B. (304) 15)